Navigation Links
Diabetes Research, Advocacy and Education Gets Big Boost with Donation of Two- Year Lease for 2008 Chrysler Sebring Convertible
Date:4/2/2008

Chrysler Sebring Convertible Winner To Be Part Of Live Auction At ADA's

16th Annual Gala At Ritz-Carlton Dearborn Donation By Chrysler Jeep Superstores Will Help Children And Teens Attend

ADA's Camp Midicha

BINGHAM FARMS, Mich., April 2, 2008 /PRNewswire/ -- Diabetes research, advocacy and education received a big boost thanks to the generous donation of a two-year lease for a 2008 Chrysler Sebring Convertible by the Chrysler Jeep Superstores, a sponsor of the American Diabetes Association 16th Annual Commitment for a Cure Gala.

The gala, held this year at 6:00 p.m., Thursday, April 10 at the Ritz-Carlton Dearborn, celebrates the contributions of volunteers and community leaders in the fight against diabetes. Proceeds fund research, diabetes education and advocacy.

The two-year lease is part of the gala's live auction that will help support the American Diabetes Association's Camp Midicha, the only residential camp in Michigan dedicated to, and designed for, children and teens with diabetes. Children aged 5 to 17 years with Types 1 and 2 diabetes can select several exciting camp experiences that include activities ranging from fishing, archery, swimming, and kayaking to underground cave excursions.

"We're very excited about the Chrysler Jeep Superstores donation of a two-year lease," said Mary C. Riegle, Director of Special Events for the American Diabetes Association. "Now is a critical time for diabetes education and advocacy. We really think that the chance to be behind the wheel of a 2008 Chrysler Sebring Convertible will be a fun way to grab people's interest in the ADA and the work that we do in Michigan," she said.

More than 815,000 children and adults in Michigan and 20.8 million nationwide have diabetes.

"We're thrilled to be a part of such an important event," said Jim Schebil, president of the Chrysler Jeep Superstores Advertising Association, a group of 39 i
'/>"/>

SOURCE Chrysler Jeep Superstores
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. American Diabetes Association Announces Multi-Year Collaboration With Colgate-Palmolive
2. Increased risk of myocardial infarction and diabetes in East Germany
3. Latest Advances in Diabetes Research to be Presented in San Francisco, California at Worlds Largest Diabetes Conference, June 6-10, 2008
4. MediPurpose Supports Diabetes Research Effort
5. Diabetes Drug Slows Clogging of Arteries
6. Lung Capacity Declines Faster With Diabetes
7. A ton of bitter melon produces sweet results for diabetes
8. Pharsight Signs New Diabetes Meta-Database Customer
9. AUDIO from Medialink and Solvay Pharmaceuticals: Men with Type 2 Diabetes at Increased Risk for Low Testosterone Should Talk to Their Doctors
10. AUDIO from Medialink and Pfizer: The 20th Annual American Diabetes Alert Day Reminds Us to Learn if We Are at Risk
11. A link between antidepressants and type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Holiday Online Auction - Dedicated to Awareness of Male Breast Cancer - Hosted by John W. Nick Foundation, Inc. at MaleBreastCancer.org 2Health News:Fleschner, Stark, Tanoos & Newlin to Offer Free Terre Haute Cab Rides on New Year's Eve 2Health News:Fleschner, Stark, Tanoos & Newlin to Offer Free Terre Haute Cab Rides on New Year's Eve 3Health News:Eligibility criteria contribute to racial disparities in hospice use 2Health News:California Woman Receives Most Advanced, Non-Invasive Upper Extremity Prosthetic Solution: Bionic i-LIMB Hand and Innovative Interface System Increase Amputee's Functionality and Confidence 2Health News:California Woman Receives Most Advanced, Non-Invasive Upper Extremity Prosthetic Solution: Bionic i-LIMB Hand and Innovative Interface System Increase Amputee's Functionality and Confidence 3Health News:California Woman Receives Most Advanced, Non-Invasive Upper Extremity Prosthetic Solution: Bionic i-LIMB Hand and Innovative Interface System Increase Amputee's Functionality and Confidence 4Health News:EnovateIT Selected by Novant Health to Update Bedside Medication Verification Program 2Health News:EnovateIT Selected by Novant Health to Update Bedside Medication Verification Program 3Health News:ProSites Attains Microsoft Certified Partner Status 2
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 2HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 3AMERIGROUP Corporation Names Two New Executives 58138 1AMERIGROUP Corporation Names Two New Executives 58138 2AMERIGROUP Corporation Names Two New Executives 58138 3Bubble Trouble Team Hits the Lab for Good Hygiene 58133 1Bubble Trouble Team Hits the Lab for Good Hygiene 58133 2Bubble Trouble Team Hits the Lab for Good Hygiene 58133 3Bubble Trouble Team Hits the Lab for Good Hygiene 58133 4Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 1Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 2Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 3
Other Medicine Technology:New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 2New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 3New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 4New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 5Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 2Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 3Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 4Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 5Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 6Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 7